Learn About Osmotic Diuresis

What is the definition of Osmotic Diuresis?

Osmotic diuresis is increased urination due to the presence of certain substances in the fluid filtered by the kidneys. This fluid eventually becomes urine. The process of osmosis created by these substances cause additional water to come into the urine, increasing its amount.

Save information for later
Sign Up
What are the causes of Osmotic Diuresis?

Osmotic diuresis can be caused by:

  • High blood sugar (glucose)
  • Use of certain medicines, such as Mannitol
Male urinary system
Who are the top Osmotic Diuresis Local Doctors?
HH
Hiddo L. Heerspink
Elite
Highly rated in
12
conditions

University Of Groningen

Groningen, GR, NL 

Hiddo Heerspink is in Groningen, Netherlands. Heerspink is rated as an Elite expert by MediFind in the treatment of Osmotic Diuresis. They are also highly rated in 12 other conditions, according to our data. Their top areas of expertise are Diabetic Nephropathy, Type 2 Diabetes, Osmotic Diuresis, and Chronic Kidney Disease.

View Profile
GB
George L. Bakris
Dr. George L. Bakris
Endocrinology | Nephrology
Distinguished
Highly rated in
28
conditions
Endocrinology
Nephrology

UChicago Medicine River East

Chicago, IL 

George Bakris is an Endocrinologist and a Nephrologist in Chicago, Illinois. Dr. Bakris has been practicing medicine for over 41 years and is rated as a Distinguished doctor by MediFind in the treatment of Osmotic Diuresis. He is also highly rated in 28 other conditions, according to our data. His top areas of expertise are Type 2 Diabetes, High Potassium Level, Diabetic Nephropathy, and Hypertension. He is board certified in Endocrinology and licensed to treat patients in Illinois. Dr. Bakris is currently accepting new patients.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
AS
Andre J. Scheen
Distinguished
Highly rated in
33
conditions

CRM/CTG: Drug Reimbursement Committee

BE 

Andre Scheen is in Belgium. Scheen is rated as a Distinguished expert by MediFind in the treatment of Osmotic Diuresis. They are also highly rated in 33 other conditions, according to our data. Their top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes, Osmotic Diuresis, and Low Blood Sugar.

View Profile
View All Doctors
What are the latest Osmotic Diuresis Clinical Trials?
Research Project: Pilot Study on Oral Urea Use in Patients at High Risk of Kidney Stone Recurrence
Status: Not yet recruiting
Start Date: December 2021
Intervention Type: Drug
Phase: Phase 2
View Trial
Summary: In clinical practice, many patients are not able to modify their habits to achieve a high level of diuresis and fluid intake and therefore are at an elevated risk for stone recurrence.~The investigators think that Ure-Na (osmotic agent) taking could help to increase urine volume and decrease urine concentration, which would be of benefit in the prevention of kidney stones.
Match to trials
Find the right clinical trials for you in under a minute
Get started
Effect of Sodium Glucose co Transporter 2 (SGLT2) Inhibition on Optical Coherence Tomography Angiography (OCT-A) Parameters in Diabetic Chronic Kidney Disease (CKD)
Who is this study for: Adult patients with diabetic chronic kidney disease
Status: Recruiting
Start Date: December 1, 2019
Intervention Type: Drug, Device
Study Drugs: Empagliflozin
Phase: Phase 4
View Trial
Summary: Diabetes mellitus is a major and growing problem worldwide with many known micro and macrovascular complications. According to International Diabetes Federation, there were 285 million adults diagnosed with diabetes in 2010 and expected to increase to 439 million adult in 2030. It is a leading cause of chronic kidney disease (CKD) followed by hypertension, glomerulonephritis, and cystic kidney dis...
View All Clinical Trials
What are the Latest Advances for Osmotic Diuresis?
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial.
Journal: Cardiovascular diabetology
Published: June 29, 2021
View publication
Summary: Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial.
Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study.
Condition: Diabetes Mellitus-Related Cardiomyopathy
Journal: BMC cardiovascular disorders
Treatment Used: Empagliflozin
Number of Patients: 35
Published: April 30, 2021
View publication
Summary: The aim of this observational study was to compare the effectiveness of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and empagliflozin treatment on left ventricular (LV) dysfunction between early and advanced diabetes mellitus-related cardiomyopathy (DMCMP).
Tired of the same old research?
Check Latest Advances
The safety outcomes of sodium-glucose cotransporter 2 inhibitors in patients with different renal function: A systematic review and meta-analysis.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: April 04, 2021
View publication
Summary: The safety outcomes of sodium-glucose cotransporter 2 inhibitors in patients with different renal function: A systematic review and meta-analysis.
View All Latest Advances
What are our references for Osmotic Diuresis?

Kamel KS, Halperin ML. Interpretation of electrolyte and acid-base parameters in blood and urine. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 24.

Pfennig CL, Slovis CM. Electrolyte disorders. In: Walls RM, Hockberger RS, Gausche-Hill M, eds. Rosen's Emergency Medicine: Concepts and Clinical Practice. 9th ed. Philadelphia, PA: Elsevier; 2018:chap 117.